— Know what they know.
Not Investment Advice

PRVA NASDAQ

Privia Health Group, Inc.
1W: +3.0% 1M: -2.0% 3M: -25.3% YTD: -13.5% 1Y: -18.7% 3Y: -8.3% 5Y: -21.3%
$20.30
+0.27 (+1.35%)
 
Weekly Expected Move ±3.1%
$19 $20 $20 $21 $22
NASDAQ · Healthcare · Medical - Healthcare Information Services · Tech Score Neutral · Power 43 · $2.6B mcap · 113M float · 1.06% daily turnover · Short 56% of daily vol

Supply Chain Overview

1 relationships
1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-05-08
Earliest Filing
2023-05-08
Latest Filing
partner: 1

Counterparties (Filed by PRVA)

1 relationships

Companies named in PRVA's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Goldman Sachs & Co. LLC GSCE partner Entered into an underwriting agreement for the sale of 42,561,196 shares of common stock. 2023-05-08 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-18 Officer/Director Change; Exhibits View
2026-08-06 Earnings Release; Exhibits View
2026-07-07 Officer/Director Change View
2026-05-22 Shareholder Vote View
2026-05-07 Earnings Release; Exhibits View
2026-02-26 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-12-08 Other Events View
2025-11-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-28 Other Events View
2025-09-23 Other Events View
2025-08-29 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-08-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-08 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-05-22 Submission of Matters to a Vote of Security Holders View
2025-05-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-07 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-02-27 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-13 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-11-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-07-03 Departure/Election of Directors; Appointment of Officers View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms